✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Lincoln Pharmaceuticals Ltd.

LINCOLN

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹1,053 Cr.
P/E
12.20

Lincoln Pharmaceuticals Ltd.

  • Lincoln Pharma
  • Kwality Pharma
  • Wanbury
  • TJI Pharma

FAQs on Lincoln Pharmaceuticals Ltd. Shareprice

Lincoln Pharma has given lower returns compared to its competitors.
Lincoln Pharma has grown at ~12.11% over the last 7yrs while peers have grown at a median rate of 30.12%

Yes, Lincoln Pharma is expensive.
Latest PE of Lincoln Pharma is 12.36, while 3 year average PE is 11.94.
Also latest EV/EBITDA of Lincoln Pharma is 10.19 while 3yr average is 9.81.

View FAQ's On Business

Growth Table

  • Lincoln Pharmaceuticals Ltd.
  • Kwality Pharma
  • Wanbury

Balance Sheet

  • Lincoln Pharmaceuticals Ltd.
  • Kwality Pharma
  • Wanbury

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Lincoln Pharmaceuticals Ltd.
  • Kwality Pharma
  • Wanbury

Cash Flow

  • Lincoln Pharmaceuticals Ltd.
  • Kwality Pharma
  • Wanbury

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Lincoln Pharmaceuticals Ltd.
  • Kwality Pharma
  • Wanbury

Quarterly Results

  • Lincoln Pharmaceuticals Ltd.
  • Kwality Pharma
  • Wanbury

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Lincoln Pharmaceuticals Ltd. Financials

Balance sheet of Lincoln Pharma is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Lincoln Pharma is decreasing.
Latest net debt of Lincoln Pharma is -₹44.36 Crs as of Mar-25.
This is less than Mar-24 when it was -₹26.03 Crs.

The profit is oscillating.
The profit of Lincoln Pharma is ₹86.35 Crs for TTM, ₹82.35 Crs for Mar 2025 and ₹93.3 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Lincoln Pharma latest dividend payout ratio is 4.38% and 3yr average dividend payout ratio is 4.12%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech